Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use
ConclusionsIntrathecal methylprednisolone acetate (Depo-Medrol) therapy seems not fully safe due to reported adverse events. The use of other forms of corticosteroid therapy free from excipients should be emphasized such as soluble methylprednisolone sodium succinate.
Source: European Spine Journal - Category: Orthopaedics Source Type: research
More News: A-Methapred | Allergy & Immunology | Anaphylactic Shock | Brain | Cardiology | Cardiovascular | Chloride | Corticosteroid Therapy | Databases & Libraries | Headache | Heart | Men | Meningitis | Methylprednisolone | Migraine | Neurology | Orthopaedics | Polyethylene Glycol | Respiratory Medicine | Sodium | Toxicology